Trevi Therapeutics Inc (TRVI)

Cash & Equivalents

$54.30M

Quarterly · Period ending: · USD

TRVI logo

TRVI Cash & Equivalents

Latest reported$18.91M
TRVI FY Cash & Equivalents ($8.29M → $18.91M)
High-resolution chart · PNG

TRVI cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
18,914,000
34,097,000
32,397,000
12,589,000
36,830,000
45,001,000
57,313,000
17,165,000
22,020,000
8,286,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.